Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms.

Marek SaracynAdam Daniel Durma Barbara Bober Maciej Kolodziej Arkadiusz LubasWaldemar KapustaStanisław NiemczykGrzegorz Kamiński

Published in: Nutrients (2022)

Though low-grade complications of radioligand therapy are possible, it stay a safe method of NEN treatment where benefits outweigh the risk.

Keyphrases